Healthcare -
Biotechnology - NASDAQ - US
$ 43.57
-12.4 %
$ 1.51 B
Market Cap
-10.75
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Disc Medicine, Inc.
| Revenue | 0 |
| Cost Of Revenue | 156 K |
| Gross Profit | -156 K |
| Operating Expenses | 130 M |
| Operating Income | -130 M |
| Other Expenses | -20.4 M |
| Net Income | -109 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.2 | 100 K | 0.3 | 0.2 | 0.3 |
| Gross Profit | (0.2) | 100 K | (0.3) | (0.2) | (0.3) |
| OPERATING INCOME | |||||
| Operating Expenses | 129.6 | 91.1 | 47.5 | 30.9 | 34.0 |
| Selling, General and Administrative Expenses | 33.0 | 21.9 | 14.0 | 5.8 | 5.9 |
| Research and Development Expenses | 96.5 | 69.2 | 33.4 | 25.2 | 28.2 |
| Operating Income | (129.7) | (91.1) | (47.5) | (30.9) | (34.0) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0.6 | 0 | 0 | 2.2 | 6.8 |
| Total Other Income | 20.7 | 14.8 | 0.6 | (5.0) | (6.8) |
| Pre-Tax Income | (109.0) | (76.3) | (46.8) | (36.0) | (40.8) |
| NET INCOME | |||||
| Tax Provision | 0.4 | 99 K | (0.7) | 5.0 | 6.8 |
| Net Income | (109.4) | (76.4) | (46.1) | (41.0) | (47.7) |
| EPS | 3.96 | 3.42 | 3.96 | 9.49 | 31.5 |